A Study of Combined Onabotulinumtoxin A and Hyaluronic Acid Filler for the Treatment of Enlarged Facial Pores.

Toxins (Basel) · 2025 · PMC11768511 · PMID 39852991

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Subsequent follow-up visits showed a decreasing trend in skin roughness for both the combination-treated side and the onaBoNT-A-treated side when compared to the baseline.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.